A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Irreversible cell growth arrest, a process termed cellular senescence, is emerging as an intrinsic tumor suppressive mechanism. Oncogene-induced senescence is thought to be invariably preceded by hyperproliferation, aberrant replication, and activation of a DNA damage checkpoint response (DDR), rendering therapeutic enhancement of this process unsuitable for cancer treatment. We previously demonstrated in a mouse model of prostate cancer that inactivation of the tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (Pten) elicits a senescence response that opposes tumorigenesis. Here, we show that Pten-loss-induced cellular senescence (PICS) represents a senescence response that is distinct from oncogene-induced senescence and can be targeted for cancer therapy. Using mouse embryonic fibroblasts, we determined that PICS occurs rapidly after Pten inactivation, in the absence of cellular proliferation and DDR. Further, we found that PICS is associated with enhanced p53 translation. Consistent with these data, we showed that in mice p53-stabilizing drugs potentiated PICS and its tumor suppressive potential. Importantly, we demonstrated that pharmacological inhibition of PTEN drives senescence and inhibits tumorigenesis in vivo in a human xenograft model of prostate cancer. Taken together, our data identify a type of cellular senescence that can be triggered in nonproliferating cells in the absence of DNA damage, which we believe will be useful for developing a "pro-senescence" approach for cancer prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although initially PTEN loss-induced cellular senescence was not associated with DDR activation40, it was later found to be associated with hyperproliferation, DDR engagement and cellular senescence in vivo41”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“However, despite this, DDR markers have a limited potential for identifying senescent cells in vivo since DDR independent mechanisms are also capable of inducing senescence via p53/p21WAF1/CIP1 pathway (Alimonti et al., 2010; Freund et al., 2011; Muñoz-Espín et al., 2013; Storer et al., 2013; Salama et al., 2014).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Alimonti et al., 2010
The cited source says what the claim attributes to it.
In the citing paper
“pharmacological inhibition of PTEN in prostate cancer that is wild type for TP53, results in the inhibition of tumorigenesis with senescence induction in a human xenograft model 152”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“TP53 up-regulation upon PTEN inhibition appears to be dependent on mTOR activity, which increases TP53 translation 152”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [152]
The cited source says what the claim attributes to it.
In the citing paper
“unlike OIS, PICS occurs in the absence of transient hyper-proliferation and a DNA damage response (DDR) 152”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [152]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Small molecule–based reversible reprogramming of cellular lifespan
Won, J., Kim, M. K., Kim, N., Ahn, J. H., Lee, W. G., Kim, S. S., Chang, K.-Y., Yi, Y.-W., & Kim, T. K. (2006) · Nature Chemical Biology · doi:10.1038/nchembio800 · Cited by 74
RetractedJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Cited by
Items 301–372 of 372
Inagaki, Y., Hashimoto, K., Wakamori, S., Katsuta, R., Yajima, A., Kaida, D., & Ishigami, K. (2024) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbae047 · Cited by 1
Advanced Models for Target Validation & Drug Discovery in Prostate Cancer
Åkerfelt, M., Härmä, V., & Nees, M. (2011) · InTech eBooks · doi:10.5772/25629 · Cited by 1
DNA Repair Defects in Prostate Cancer Cells in Response to Radiation
Chatterjee, P. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Potential Applications of Aptamers for Targeting Senescent Cells
Leonardi, A., Pacifico, F., & Crescenzi, E. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_10 · Cited by 1
To G0 or Not to G0: Cell Cycle Paradox in Senescence and Brain Aging
Ishikawa, S., & Ishikawa, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_5 · Cited by 1
Lautrup, S., Anisimov, A. S., Lagartos-Donate, M. J., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00010-9 · Cited by 4
Mechanisms of resistance to lapatinib in HER2 positive breast cancer
McDermott, M. S. J. (2012) · Dublin City University Open Access Institutional Repository (Dublin City University) · Cited by 1
Gilbert, C. A. (2011) · eScholarship@UMassChan · doi:10.13028/a7fz-f103 · Cited by 1
Regulation of the Novel Senescence Pathway by SKP2 E3 Ligase
Wang, G., Gao, Y., Chen, L., Wang, Y. J., & Lin, H.-K. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_4
Induction of cellular senescence as a novel therapeutic strategy for melanoma treatment
Zhang, G. (2012) · ScholarlyCommons (University of Pennsylvania)
Tait, I. (2014) · Tuwhera (Auckland University of Technology)
Vilar, J. B. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-24022015-105346
The Role of Phosphoinositide 3-Kinase in Breast Cancer
Yuan, T. L. (2010) · Defense Technical Information Center (DTIC) · doi:10.21236/ada541781
In vivo elucidation of PIM kinase role in tumourigenesis
Grassow, M. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Translational Control of Cell Proliferation and Viability in Normal and Neoplastic Cells
Avdulov, S. V., Gómez-García, J. R., Bitterman, P. B., & Polunovsky, V. A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_18
Aging, Nutrient Signaling, Hematopoietic Senescence, and Cancer
Balasubramanian, P., & Longo, V. D. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013010596
Pernicová, Z., Vaňhara, P., & Souček, K. (2013) · Springer eBooks · doi:10.1007/978-94-007-5958-9_26
[Arterial opacification in the anatomo-pathologic test of the fetus].
Weichhold, W., Carles, D., Serville, F., & Alberti, E. M. (1989) · PubMed
her2 hyper-activation through the production of carboxy-terminal fragments
Angelini, P. D. (2014) · TDX (Tesis Doctorals en Xarxa)
Loss of BRCA1 in Normal Human Mammary Epithelial Cells Induces a Novel Mechanism of Senescence
Noor, S. (2011) · TSpace (University of Toronto)
Can we rejuvenate? Implications of biological aging research
Son, Y., & Kim, J. R. (2017) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2017.34.1.1
barrier in prostate lesions of Pten-knockout mouse
Wang, L., Guo, X., Wang, J., Jiang, C., Bosland, M. C., Lü, J., Deng, Y., & Coulter, S. (2015)
Zytokin-induzierte Seneszenz: eine experimentelle Therapie peritonealer Tumoren
Wieder, T., Brenner, E., Braumüller, H., & Röcken, M. (2018) · Springer eBooks · doi:10.1007/978-3-662-54500-3_14
Vázquez-Villaseñor, I. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Cellular Senescence and Tumor Promotion
Demaria, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-44870-1_79-1
Naimo, M. A. (2019) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4094 · Cited by 1
Cytokine-Induced Senescence: An Experimental Treatment of Peritoneal Tumors
Wieder, T., Brenner, E., Braumüller, H., Garg, P. K., & Röcken, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-62640-2_14
Rizos, H., & Scurr, L. L. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0371-5_11
Rizos, H., Haferkamp, S., & Scurr, L. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-41319-8_11 · Cited by 1
Cells, cytokines, and factors involved in profibrogenic pathways
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00014-7
Küçükgüven, A., & Vargel, İ. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98804-9.00003-7
Preclinical evaluation of senescence-based strategies to improve cancer therapy
Estepa‐Fernández, A. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/188845
PTEN Knockout Causes Premature Senescence of Human Endometrial Stromal Cells
Parfenova, P. S., Deryabin, P. I., Pozdnyakov, D. Y., & Borodkina, A. V. (2024) · Cell and Tissue Biology · doi:10.1134/s1990519x24700330 · Cited by 1
PTEN knockout leads to premature senescence of human endometrial stromal cells
Parfenova, P. S., Deryabin, P. I., Pozdnyakov, D. Y., & Borodkina, A. V. (2024) · Tsitologiya · doi:10.31857/s0041377124020035
Cellular Senescence and Cancer
Moar, K., Kakde, G. S., & Maurya, P. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_10 · Cited by 1
Pierdoná, V., Lavandoski, P., Maurmann, R. M., Borges, G. A., Mombach, J. C. M., Guma, F. T. C. R., & Barbé‐Tuana, F. M. (2025) · Aging Medicine · doi:10.1002/agm2.70020
Álvarez-Arzola, R., Bancaro, N., Lai, P., Attanasio, G., Pellegrini, L., Troiani, M., Colucci, M., Mosole, S., Pasquini, E., Alimonti, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26582018
Self-citationÁlvarez-Arzola, R., Bancaro, N., Lai, P., Attanasio, G., Pellegrini, L., Troiani, M., Colucci, M., Mosole, S., Pasquini, E., Alimonti, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26582015
Self-citationÁlvarez-Arzola, R., Bancaro, N., Lai, P., Attanasio, G., Pellegrini, L., Troiani, M., Colucci, M., Mosole, S., Pasquini, E., Alimonti, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26582012
Self-citationグルタミントランスポーターSLC1A5の標的化は淡明細胞型腎細胞癌において細胞老化を誘導する
Kawakami, I. (2023) · Kagoshima University Repository
Eosinophilic Cells in Endometrial Carcinoma as a Predictor of BRAF Mutation: Report of 2 Cases
Lavis, P., D’Haene, N., Noël, J., & Catteau, X. (2026) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000001162
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)
Pederzoli, F., Pakula, H., Rodrigues, S. D., Garner, R., Nuzzo, P. V., Bleve, S., Rickman, D. S., Fanelli, G. N., & Loda, M. F. (2026) · Gene · doi:10.1016/j.gene.2026.150131 · Cited by 2
Lima‐Fernandes, E. (2012) · theses.fr (ABES) · doi:10.70675/dc75b7cbz5451z4999za5e5z58fe19782ff1
Kahli, M. (2011) · theses.fr (ABES) · doi:10.70675/bc7bcb93z46bdz473aza3ebz5cc713b77897 · Cited by 1
Sénescence cellulaire et nouvelles approches thérapeutiques de l'hypertension artérielle pulmonaire
Mouraret, N. (2013) · theses.fr (ABES) · doi:10.70675/b2ae892dzafc0z4b55z9d55zb8908a6a07c7
Rôle de la kinase Akt dans la chimiorésistance : Régulation de l’équilibre Apoptose-Sénescence
Vétillard, A. (2015) · theses.fr (ABES) · doi:10.70675/d0db61dazb197z42dczbb98z6f0276f570b6
Tuberous sclerosis complex : molecular target of mTORC1 and the role of S6Ks
Bonucci, M. (2019) · theses.fr (ABES) · doi:10.70675/fd5e0059z9c7bz468ezb8bdz4c2214da80c2
The role of Activin signaling pathway in the initiation and progression of pancreatic cancer
Zhao, Y. (2019) · theses.fr (ABES) · doi:10.70675/17612dbdz6d94z4563z86a3z6d1e91b34f9b
Generation of antisense RNAs at convergent gene loci in cells undergoing senescence
Deb, M. K. (2016) · theses.fr (ABES) · doi:10.70675/739ebf07zf620z4e1fzb0d4z02066589491f
Characterization of Pten and Trp53 deficient prostatic tumors in mice
Bizri, R. E. (2018) · theses.fr (ABES) · doi:10.70675/887a45dbz93f0z4790z9840z71a317de4d2f
An RNA Signature Links Oxidative Stress To Cellular Senescence
Mullani, N. (2019) · theses.fr (ABES) · doi:10.70675/1babf95cz77a0z4561za6cdz6bf733f9f455
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
Contrôle de l'oncogenicité de Kras et isoforme beta de PI3K dans la cancérogenèse du pancréas
Arcucci, S. (2019) · theses.fr (ABES) · doi:10.70675/bd0f6cf8zac49z4e36zbe80z39b5e2b4e43a
Christoffersen, J., Bjørndal, L., & Dabelsteen, S. (2026) · Bioengineering · doi:10.3390/bioengineering13060654
The multifaceted inducers of cellular senescence
Gal, H., & Krizhanovsky, V. (2026) · Aging · doi:10.18632/aging.206391
Orchestration of Autophagy and Senescence: Kinases Take the Center Stage
Basu, A. (2026) · Cells · doi:10.3390/cells15131176
The Emerging Role of mTOR in Shaping the Cancer Cell Secretome and Plasticity
Cooper, T. T., Topisirović, I., & Postovit, L.-M. M. (2026) · Molecular and Cellular Biology · doi:10.1080/10985549.2026.2699146
Han, Y., Ma, L., & Ma, X. (2026) · Biology Direct · doi:10.1186/s13062-026-00908-y · Cited by 1
Zhang, Q., Shen, K., & Liu, S. (2026) · Cells · doi:10.3390/cells15161457 · Cited by 1
Lemos, I. L., Gianchetto, J. D. S., Vecchi, A. C. T., Rezende, B. B., Santos, F. R., Montico, F., Cagnon, V. H. A., & Maróstica, M. R. (2026) · Food Research International · doi:10.1016/j.foodres.2026.120529
Matveeva, K. S., & Shevyrev, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188416
Lin, C., 郭倩钰, & Lai, S. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101369
Hao, J., Luo, X., Zhu, Z.-H., Zhao, X., Huang, X.-C., He, J., Xu, W.-X., Zeng, H.-Y., Liu, G.-S., Li, L., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01898-0
The Senescent Cell Induced Bystander Effect
Wordsworth, J. (2014)
Metadata
- Authors
- Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H. I., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Cincinnati (US)
- Imperial College London (GB)
- Instituto Nazionale Tumori Regina Elena (IT)
- Corresponding author
- Pandolfi, Pier Paolo
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2010-03-01
- Volume
- 120
- Issue
- 3
- Pages
- 681-693
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2827955
- OpenAlex
- W2005250235
- Cited by
- 374
- References
- 46
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 23 · 2023: 12 · 2022: 24 · 2021: 18 · 2020: 30 · 2019: 17 · 2018: 27 · 2017: 17 · 2016: 20 · 2015: 20 · 2014: 28 · 2013: 25 · 2012: 27
- FWCI
- 23.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Iris (University of Trento) (submittedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- UCL Discovery (University College London) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Prostate Cancer Foundation
- American-Italian Cancer Foundation
- Associazione Italiana di Oncologia Medica
- National Institutes of Health
- National Cancer Institute (R01CA137050)
- National Institute on Minority Health and Health Disparities (R01MD004038)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, PTEN inactivation, prostate cancer, tumor suppression, DNA damage response, non-proliferating cells, tumor xenografts
- MeSH terms
- Animals, Disease Models, Animal, DNA Damage, Embryo, Mammalian, Fibroblasts, Humans, Male, Neoplasm Transplantation, Prostatic Neoplasms, Protein Biosynthesis, Transplantation, Heterologous, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Mice, Knockout, Cell Line, Tumor, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.